Biofarm Sp. z o.o.,Vigalex Bio 1000 IU 90 tablets,Vigalex Bio 1000 IU 90 tabl.

Vigalex Bio 1000 IU is a drug for adults and children over 6 years of age with normal body weight. The active ingredient of the drug is vitamin D3.
Properties: Vigalex Forte with vitamin D3 (cholecalciferol), important in the process of bone tissue formation. Vitamin D3 (cholecalciferol) is produced by the body in the skin under the influence of sunlight (UV radiation), and it can also be ingested through food. Vitamin D3 prevents the disorders of bone calcification (rickets) or loss of calcium from bones (osteomalacia) and supports the proper functioning of the immune system.
Composition: One tablet contains 10 mg of cholecalciferol powder, which is equivalent to 0.025 mg (1000 IU) of cholecalciferol (vitamin D3). Other Ingredients: Microcrystalline cellulose (type 102), calcium hydrogen phosphate dihydrate, pregelatinized corn starch, crospovidone (type A), sucrose, magnesium stearate, sodium ascorbate, medium chain saturated fatty acid triglycerides, colloidal anhydrous silica, all-rac. -α-Tocopherol.
Application: Children from 6 to 10 years old with normal body weight: 1000 IU per day. Youth from 11 to 18 years old with normal body weight. Prevention of vitamin D deficiency: 1000 to 2000 IU per day, Prevention of rickets and osteomalacia: 2000 IU per day, Adults with normal body weight Prevention of vitamin D deficiency: 1000 to 2000 IU per day, Prevention of rickets and osteomalacia: 2000 IU per day , supporting the treatment of osteoporosis: 2000 to 4000 IU per day. Women planning pregnancy, pregnant or breastfeeding Please consult your doctor to determine the dose of vitamin D you should take during pregnancy. The generally recommended dosage is 2,000 IU per day, regardless of season, unless your doctor recommends a different dosing method. The tablet should be taken with a sufficient amount of liquid.
Important information: Do not use in case of: Hypersensitivity to the active substance (cholecalciferol) or to any of the excipients. Hypercalcemia and/or hypercalciuria, Kidney stones and/or severe renal failure, Pseudohypoparathyroidism (the need for vitamin D may be reduced due to periods of normal sensitivity to this vitamin, leading to overdose). In this case, more manageable vitamin D derivatives are available.